GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Cash Flow from Investing

Fisher & Paykel Healthcare (NZSE:FPH) Cash Flow from Investing : NZ$-362 Mil (TTM As of Sep. 2023)


View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Sep. 2023, Fisher & Paykel Healthcare spent NZ$264 Mil on purchasing property, plant, equipment. It gained NZ$0 Mil from selling property, plant, and equipment. It spent NZ$0 Mil on purchasing business. It gained NZ$0 Mil from selling business. It spent NZ$0 Mil on purchasing investments. It gained NZ$0 Mil from selling investments. It paid NZ$12Mil for net Intangibles purchase and sale. And it paid NZ$0 Mil for other investing activities. In all, Fisher & Paykel Healthcare spent NZ$276 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Sep. 2023.


Fisher & Paykel Healthcare Cash Flow from Investing Historical Data

The historical data trend for Fisher & Paykel Healthcare's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Cash Flow from Investing Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -125.70 -155.70 -387.30 -89.50 -11.30

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.80 -103.30 75.20 -86.50 -275.50

Fisher & Paykel Healthcare Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Fisher & Paykel Healthcare's Cash Flow from Investing for the fiscal year that ended in Mar. 2023 is calculated as:

Fisher & Paykel Healthcare's Cash Flow from Investing for the quarter that ended in Sep. 2023 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$-362 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fisher & Paykel Healthcare  (NZSE:FPH) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Fisher & Paykel Healthcare's purchase of property, plant, equipment for the six months ended in Sep. 2023 was NZ$-264 Mil. It means Fisher & Paykel Healthcare spent NZ$264 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Fisher & Paykel Healthcare's sale of property, plant, equipment for the six months ended in Sep. 2023 was NZ$0 Mil. It means Fisher & Paykel Healthcare gained NZ$0 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Fisher & Paykel Healthcare's purchase of business for the six months ended in Sep. 2023 was NZ$0 Mil. It means Fisher & Paykel Healthcare spent NZ$0 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Fisher & Paykel Healthcare's sale of business for the six months ended in Sep. 2023 was NZ$0 Mil. It means Fisher & Paykel Healthcare gained NZ$0 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Fisher & Paykel Healthcare's purchase of investment for the six months ended in Sep. 2023 was NZ$0 Mil. It means Fisher & Paykel Healthcare spent {stock_data.stock.currency_symbol}}0 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Fisher & Paykel Healthcare's sale of investment for the six months ended in Sep. 2023 was NZ$0 Mil. It means Fisher & Paykel Healthcare gained NZ$0 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Fisher & Paykel Healthcare's net Intangibles purchase and sale for the six months ended in Sep. 2023 was NZ$-12 Mil. It means Fisher & Paykel Healthcare paid NZ$12 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Fisher & Paykel Healthcare's cash from discontinued investing activities for the six months ended in Sep. 2023 was 0 Mil. It means Fisher & Paykel Healthcare paid NZ$0 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Fisher & Paykel Healthcare's cash from other investing activities for the six months ended in Sep. 2023 was NZ$-0 Mil. It means Fisher & Paykel Healthcare paid NZ$0 Mil for other investing activities.


Fisher & Paykel Healthcare Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.